279 East Grand Avenue
5th Floor
South San Francisco
United States

Tel: (650) 446-6630


Featured Employer
NextGen Class of 2018
Show jobs for this employer

About Freenome


Freenome is a high growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.


To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. 


We have raised more than $1.1B from leading investors including Andreessen Horowitz, Bain Capital, GV, Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Novartis, Verily, and more. 


A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career. 


Facebook     Twitter  

What is Freenome? First and foremost, Freenome is a team. A cross-collaborative, mission-driven team developing next-generation blood tests for early cancer detection, so that we can find cancer when it’s most treatable.

47 articles about Freenome